Tsumura & Co
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $1.43 billion
- Book Value:
- Revenue TTM:
- $142.66 billion
- Operating Margin TTM:
- Gross Profit TTM:
- $66.47 billion
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Tsumura & Co had its IPO on under the ticker symbol TSMRF.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Tsumura & Co has a staff strength of 3,921 employees.
Shares of Tsumura & Co opened at $21.95 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $21.95 - $21.95, and closed at $21.95.
This is a +7.44% increase from the previous day's closing price.
A total volume of 100 shares were traded at the close of the day’s session.
In the last one week, shares of Tsumura & Co have slipped by -29.38%.
Tsumura & Co's Key Ratios
Tsumura & Co has a market cap of $1.43 billion, indicating a price to book ratio of 0.8304 and a price to sales ratio of 0.0134.
In the last 12-months Tsumura & Co’s revenue was $142.66 billion with a gross profit of $66.47 billion and an EBITDA of $29.87 billion. The EBITDA ratio measures Tsumura & Co's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Tsumura & Co’s operating margin was 13.49% while its return on assets stood at 3.13% with a return of equity of 5.47%.
In Q4, Tsumura & Co’s quarterly earnings growth was a negative -34.4% while revenue growth was a positive 7.6%.
Tsumura & Co’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $1.26 per share while it has a forward price to earnings multiple of 12.21 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Tsumura & Co’s profitability.
Tsumura & Co stock is trading at a EV to sales ratio of 0.0111 and a EV to EBITDA ratio of 0.0396. Its price to sales ratio in the trailing 12-months stood at 0.0134.
Tsumura & Co stock pays annual dividends of $64 per share, indicating a yield of 2.59% and a payout ratio of 93.41%.
Balance sheet and cash flow metrics
- Total Assets
- $400.96 billion
- Total Liabilities
- $43.70 billion
- Operating Cash Flow
- Capital Expenditure
- $4.09 billion
- Dividend Payout Ratio
Tsumura & Co ended 2023 with $400.96 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $400.96 billion while shareholder equity stood at $257.77 billion.
Tsumura & Co ended 2023 with $0 in deferred long-term liabilities, $43.70 billion in other current liabilities, in common stock, $193.62 billion in retained earnings and $9.22 billion in goodwill. Its cash balance stood at $93.73 billion and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $69.38 billion.
Tsumura & Co’s total current assets stands at $270.96 billion while long-term investments were $0 and short-term investments were $0. Its net receivables were $61.86 billion compared to accounts payable of $13.45 billion and inventory worth $101.08 billion.
In 2023, Tsumura & Co's operating cash flow was $0 while its capital expenditure stood at $4.09 billion.
Comparatively, Tsumura & Co paid $0.93 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Tsumura & Co stock is currently trading at $21.95 per share. It touched a 52-week high of $21.95 and a 52-week low of $21.95. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $28.23 and 200-day moving average was $0 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 908.5% of the company’s stock are held by insiders while 3766% are held by institutions.
Frequently Asked Questions About Tsumura & Co
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Tsumura & Co. engages in the manufacture and sale of pharmaceutical products worldwide. The company offers Kampo extract intermediates and granular Kampo formulations. It is involved in the procurement, selection and processing, and storage of raw material crude drugs and crude drug pieces for decoction; manufacture of Kampo powdered extracts and traditional Chinese medicines; and sale of pharmaceuticals and food products. The company was founded in 1893 and is headquartered in Tokyo, Japan.